As a result, the GEPIA-based analysis indicated that NCBP2 was upregulated in 17 of 33 cancer types, including hepatocellular carcinoma, which was computed in the form of transcripts per million compared with adjacent tissues (Figure 5A). Here, NCBP2 is linked to cancer.